Therapeutic recombinant proteins are proteins that are produced by recombinant DNA technology and are used as drugs to treat various medical conditions. Recombinant DNA technology involves the use of genetically engineered microorganisms or cells to produce large quantities of a specific protein that has therapeutic potential. Therapeutic recombinant proteins are used to treat a wide range of medical conditions, including cancer, autoimmune diseases, genetic disorders, and infectious diseases. These proteins are designed to mimic the natural proteins in the body that regulate various biological processes. They are often administered by injection, and their effectiveness depends on the specific protein and the medical condition being treated.

The global Therapeutic Recombinant Protein market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Therapeutic Recombinant Protein, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Therapeutic Recombinant Protein.

Report Scope

The Therapeutic Recombinant Protein market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Therapeutic Recombinant Protein market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Therapeutic Recombinant Protein companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Therapeutic Recombinant Protein Market Report

Report Metric	Details
Report Name	Therapeutic Recombinant Protein Market
CAGR	5%
Segment by Type	Hormones Blood Clotting Factors Cytokines Enzymes Fusion Proteins Others
Segment by Application	Pharmaceutical Company Research Institute Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Abcam, HALIX, Avantor, Miltenyi Biotec, Thermo Fisher Scientific, Bio-Techne Corporation, Merck, ACROBiosystems, Abnova, Eurogentec (Kaneka Corporation), Cytiva (Danaher ), Reprocell, GenScript, BPS Bioscience, Sino Biological
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Therapeutic Recombinant Protein companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Therapeutic Recombinant Protein Market report?

Ans: The main players in the Therapeutic Recombinant Protein Market are Abcam, HALIX, Avantor, Miltenyi Biotec, Thermo Fisher Scientific, Bio-Techne Corporation, Merck, ACROBiosystems, Abnova, Eurogentec (Kaneka Corporation), Cytiva (Danaher ), Reprocell, GenScript, BPS Bioscience, Sino Biological

What are the Application segmentation covered in the Therapeutic Recombinant Protein Market report?

Ans: The Applications covered in the Therapeutic Recombinant Protein Market report are Pharmaceutical Company, Research Institute, Others

What are the Type segmentation covered in the Therapeutic Recombinant Protein Market report?

Ans: The Types covered in the Therapeutic Recombinant Protein Market report are Hormones, Blood Clotting Factors, Cytokines, Enzymes, Fusion Proteins, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Therapeutic Recombinant Protein Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Hormones

1.2.3 Blood Clotting Factors

1.2.4 Cytokines

1.2.5 Enzymes

1.2.6 Fusion Proteins

1.2.7 Others

1.3 Market by Application

1.3.1 Global Therapeutic Recombinant Protein Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Pharmaceutical Company

1.3.3 Research Institute

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Therapeutic Recombinant Protein Market Perspective (2019-2030)

2.2 Therapeutic Recombinant Protein Growth Trends by Region

2.2.1 Global Therapeutic Recombinant Protein Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Therapeutic Recombinant Protein Historic Market Size by Region (2019-2024)

2.2.3 Therapeutic Recombinant Protein Forecasted Market Size by Region (2025-2030)

2.3 Therapeutic Recombinant Protein Market Dynamics

2.3.1 Therapeutic Recombinant Protein Industry Trends

2.3.2 Therapeutic Recombinant Protein Market Drivers

2.3.3 Therapeutic Recombinant Protein Market Challenges

2.3.4 Therapeutic Recombinant Protein Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Therapeutic Recombinant Protein Players by Revenue

3.1.1 Global Top Therapeutic Recombinant Protein Players by Revenue (2019-2024)

3.1.2 Global Therapeutic Recombinant Protein Revenue Market Share by Players (2019-2024)

3.2 Global Therapeutic Recombinant Protein Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Therapeutic Recombinant Protein Revenue

3.4 Global Therapeutic Recombinant Protein Market Concentration Ratio

3.4.1 Global Therapeutic Recombinant Protein Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Therapeutic Recombinant Protein Revenue in 2023

3.5 Therapeutic Recombinant Protein Key Players Head office and Area Served

3.6 Key Players Therapeutic Recombinant Protein Product Solution and Service

3.7 Date of Enter into Therapeutic Recombinant Protein Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Therapeutic Recombinant Protein Breakdown Data by Type

4.1 Global Therapeutic Recombinant Protein Historic Market Size by Type (2019-2024)

4.2 Global Therapeutic Recombinant Protein Forecasted Market Size by Type (2025-2030)

5 Therapeutic Recombinant Protein Breakdown Data by Application

5.1 Global Therapeutic Recombinant Protein Historic Market Size by Application (2019-2024)

5.2 Global Therapeutic Recombinant Protein Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Therapeutic Recombinant Protein Market Size (2019-2030)

6.2 North America Therapeutic Recombinant Protein Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Therapeutic Recombinant Protein Market Size by Country (2019-2024)

6.4 North America Therapeutic Recombinant Protein Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Therapeutic Recombinant Protein Market Size (2019-2030)

7.2 Europe Therapeutic Recombinant Protein Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Therapeutic Recombinant Protein Market Size by Country (2019-2024)

7.4 Europe Therapeutic Recombinant Protein Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Therapeutic Recombinant Protein Market Size (2019-2030)

8.2 Asia-Pacific Therapeutic Recombinant Protein Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Therapeutic Recombinant Protein Market Size by Region (2019-2024)

8.4 Asia-Pacific Therapeutic Recombinant Protein Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Therapeutic Recombinant Protein Market Size (2019-2030)

9.2 Latin America Therapeutic Recombinant Protein Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Therapeutic Recombinant Protein Market Size by Country (2019-2024)

9.4 Latin America Therapeutic Recombinant Protein Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Therapeutic Recombinant Protein Market Size (2019-2030)

10.2 Middle East & Africa Therapeutic Recombinant Protein Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Therapeutic Recombinant Protein Market Size by Country (2019-2024)

10.4 Middle East & Africa Therapeutic Recombinant Protein Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Abcam

11.1.1 Abcam Company Detail

11.1.2 Abcam Business Overview

11.1.3 Abcam Therapeutic Recombinant Protein Introduction

11.1.4 Abcam Revenue in Therapeutic Recombinant Protein Business (2019-2024)

11.1.5 Abcam Recent Development

11.2 HALIX

11.2.1 HALIX Company Detail

11.2.2 HALIX Business Overview

11.2.3 HALIX Therapeutic Recombinant Protein Introduction

11.2.4 HALIX Revenue in Therapeutic Recombinant Protein Business (2019-2024)

11.2.5 HALIX Recent Development

11.3 Avantor

11.3.1 Avantor Company Detail

11.3.2 Avantor Business Overview

11.3.3 Avantor Therapeutic Recombinant Protein Introduction

11.3.4 Avantor Revenue in Therapeutic Recombinant Protein Business (2019-2024)

11.3.5 Avantor Recent Development

11.4 Miltenyi Biotec

11.4.1 Miltenyi Biotec Company Detail

11.4.2 Miltenyi Biotec Business Overview

11.4.3 Miltenyi Biotec Therapeutic Recombinant Protein Introduction

11.4.4 Miltenyi Biotec Revenue in Therapeutic Recombinant Protein Business (2019-2024)

11.4.5 Miltenyi Biotec Recent Development

11.5 Thermo Fisher Scientific

11.5.1 Thermo Fisher Scientific Company Detail

11.5.2 Thermo Fisher Scientific Business Overview

11.5.3 Thermo Fisher Scientific Therapeutic Recombinant Protein Introduction

11.5.4 Thermo Fisher Scientific Revenue in Therapeutic Recombinant Protein Business (2019-2024)

11.5.5 Thermo Fisher Scientific Recent Development

11.6 Bio-Techne Corporation

11.6.1 Bio-Techne Corporation Company Detail

11.6.2 Bio-Techne Corporation Business Overview

11.6.3 Bio-Techne Corporation Therapeutic Recombinant Protein Introduction

11.6.4 Bio-Techne Corporation Revenue in Therapeutic Recombinant Protein Business (2019-2024)

11.6.5 Bio-Techne Corporation Recent Development

11.7 Merck

11.7.1 Merck Company Detail

11.7.2 Merck Business Overview

11.7.3 Merck Therapeutic Recombinant Protein Introduction

11.7.4 Merck Revenue in Therapeutic Recombinant Protein Business (2019-2024)

11.7.5 Merck Recent Development

11.8 ACROBiosystems

11.8.1 ACROBiosystems Company Detail

11.8.2 ACROBiosystems Business Overview

11.8.3 ACROBiosystems Therapeutic Recombinant Protein Introduction

11.8.4 ACROBiosystems Revenue in Therapeutic Recombinant Protein Business (2019-2024)

11.8.5 ACROBiosystems Recent Development

11.9 Abnova

11.9.1 Abnova Company Detail

11.9.2 Abnova Business Overview

11.9.3 Abnova Therapeutic Recombinant Protein Introduction

11.9.4 Abnova Revenue in Therapeutic Recombinant Protein Business (2019-2024)

11.9.5 Abnova Recent Development

11.10 Eurogentec (Kaneka Corporation)

11.10.1 Eurogentec (Kaneka Corporation) Company Detail

11.10.2 Eurogentec (Kaneka Corporation) Business Overview

11.10.3 Eurogentec (Kaneka Corporation) Therapeutic Recombinant Protein Introduction

11.10.4 Eurogentec (Kaneka Corporation) Revenue in Therapeutic Recombinant Protein Business (2019-2024)

11.10.5 Eurogentec (Kaneka Corporation) Recent Development

11.11 Cytiva (Danaher )

11.11.1 Cytiva (Danaher ) Company Detail

11.11.2 Cytiva (Danaher ) Business Overview

11.11.3 Cytiva (Danaher ) Therapeutic Recombinant Protein Introduction

11.11.4 Cytiva (Danaher ) Revenue in Therapeutic Recombinant Protein Business (2019-2024)

11.11.5 Cytiva (Danaher ) Recent Development

11.12 Reprocell

11.12.1 Reprocell Company Detail

11.12.2 Reprocell Business Overview

11.12.3 Reprocell Therapeutic Recombinant Protein Introduction

11.12.4 Reprocell Revenue in Therapeutic Recombinant Protein Business (2019-2024)

11.12.5 Reprocell Recent Development

11.13 GenScript

11.13.1 GenScript Company Detail

11.13.2 GenScript Business Overview

11.13.3 GenScript Therapeutic Recombinant Protein Introduction

11.13.4 GenScript Revenue in Therapeutic Recombinant Protein Business (2019-2024)

11.13.5 GenScript Recent Development

11.14 BPS Bioscience

11.14.1 BPS Bioscience Company Detail

11.14.2 BPS Bioscience Business Overview

11.14.3 BPS Bioscience Therapeutic Recombinant Protein Introduction

11.14.4 BPS Bioscience Revenue in Therapeutic Recombinant Protein Business (2019-2024)

11.14.5 BPS Bioscience Recent Development

11.15 Sino Biological

11.15.1 Sino Biological Company Detail

11.15.2 Sino Biological Business Overview

11.15.3 Sino Biological Therapeutic Recombinant Protein Introduction

11.15.4 Sino Biological Revenue in Therapeutic Recombinant Protein Business (2019-2024)

11.15.5 Sino Biological Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Thermo Fisher Scientific

Bio Techne Corporation

Merck

ACROBiosystems

Abnova

Eurogentec (Kaneka Corporation)

List of Tables

Table 1. Global Therapeutic Recombinant Protein Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Hormones

Table 3. Key Players of Blood Clotting Factors

Table 4. Key Players of Cytokines

Table 5. Key Players of Enzymes

Table 6. Key Players of Fusion Proteins

Table 7. Key Players of Others

Table 8. Global Therapeutic Recombinant Protein Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 9. Global Therapeutic Recombinant Protein Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 10. Global Therapeutic Recombinant Protein Market Size by Region (2019-2024) & (US$ Million)

Table 11. Global Therapeutic Recombinant Protein Market Share by Region (2019-2024)

Table 12. Global Therapeutic Recombinant Protein Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 13. Global Therapeutic Recombinant Protein Market Share by Region (2025-2030)

Table 14. Therapeutic Recombinant Protein Market Trends

Table 15. Therapeutic Recombinant Protein Market Drivers

Table 16. Therapeutic Recombinant Protein Market Challenges

Table 17. Therapeutic Recombinant Protein Market Restraints

Table 18. Global Therapeutic Recombinant Protein Revenue by Players (2019-2024) & (US$ Million)

Table 19. Global Therapeutic Recombinant Protein Market Share by Players (2019-2024)

Table 20. Global Top Therapeutic Recombinant Protein Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Therapeutic Recombinant Protein as of 2023)

Table 21. Ranking of Global Top Therapeutic Recombinant Protein Companies by Revenue (US$ Million) in 2023

Table 22. Global 5 Largest Players Market Share by Therapeutic Recombinant Protein Revenue (CR5 and HHI) & (2019-2024)

Table 23. Key Players Headquarters and Area Served

Table 24. Key Players Therapeutic Recombinant Protein Product Solution and Service

Table 25. Date of Enter into Therapeutic Recombinant Protein Market

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. Global Therapeutic Recombinant Protein Market Size by Type (2019-2024) & (US$ Million)

Table 28. Global Therapeutic Recombinant Protein Revenue Market Share by Type (2019-2024)

Table 29. Global Therapeutic Recombinant Protein Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 30. Global Therapeutic Recombinant Protein Revenue Market Share by Type (2025-2030)

Table 31. Global Therapeutic Recombinant Protein Market Size by Application (2019-2024) & (US$ Million)

Table 32. Global Therapeutic Recombinant Protein Revenue Market Share by Application (2019-2024)

Table 33. Global Therapeutic Recombinant Protein Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 34. Global Therapeutic Recombinant Protein Revenue Market Share by Application (2025-2030)

Table 35. North America Therapeutic Recombinant Protein Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. North America Therapeutic Recombinant Protein Market Size by Country (2019-2024) & (US$ Million)

Table 37. North America Therapeutic Recombinant Protein Market Size by Country (2025-2030) & (US$ Million)

Table 38. Europe Therapeutic Recombinant Protein Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 39. Europe Therapeutic Recombinant Protein Market Size by Country (2019-2024) & (US$ Million)

Table 40. Europe Therapeutic Recombinant Protein Market Size by Country (2025-2030) & (US$ Million)

Table 41. Asia-Pacific Therapeutic Recombinant Protein Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 42. Asia-Pacific Therapeutic Recombinant Protein Market Size by Region (2019-2024) & (US$ Million)

Table 43. Asia-Pacific Therapeutic Recombinant Protein Market Size by Region (2025-2030) & (US$ Million)

Table 44. Latin America Therapeutic Recombinant Protein Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Latin America Therapeutic Recombinant Protein Market Size by Country (2019-2024) & (US$ Million)

Table 46. Latin America Therapeutic Recombinant Protein Market Size by Country (2025-2030) & (US$ Million)

Table 47. Middle East & Africa Therapeutic Recombinant Protein Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 48. Middle East & Africa Therapeutic Recombinant Protein Market Size by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Therapeutic Recombinant Protein Market Size by Country (2025-2030) & (US$ Million)

Table 50. Abcam Company Detail

Table 51. Abcam Business Overview

Table 52. Abcam Therapeutic Recombinant Protein Product

Table 53. Abcam Revenue in Therapeutic Recombinant Protein Business (2019-2024) & (US$ Million)

Table 54. Abcam Recent Development

Table 55. HALIX Company Detail

Table 56. HALIX Business Overview

Table 57. HALIX Therapeutic Recombinant Protein Product

Table 58. HALIX Revenue in Therapeutic Recombinant Protein Business (2019-2024) & (US$ Million)

Table 59. HALIX Recent Development

Table 60. Avantor Company Detail

Table 61. Avantor Business Overview

Table 62. Avantor Therapeutic Recombinant Protein Product

Table 63. Avantor Revenue in Therapeutic Recombinant Protein Business (2019-2024) & (US$ Million)

Table 64. Avantor Recent Development

Table 65. Miltenyi Biotec Company Detail

Table 66. Miltenyi Biotec Business Overview

Table 67. Miltenyi Biotec Therapeutic Recombinant Protein Product

Table 68. Miltenyi Biotec Revenue in Therapeutic Recombinant Protein Business (2019-2024) & (US$ Million)

Table 69. Miltenyi Biotec Recent Development

Table 70. Thermo Fisher Scientific Company Detail

Table 71. Thermo Fisher Scientific Business Overview

Table 72. Thermo Fisher Scientific Therapeutic Recombinant Protein Product

Table 73. Thermo Fisher Scientific Revenue in Therapeutic Recombinant Protein Business (2019-2024) & (US$ Million)

Table 74. Thermo Fisher Scientific Recent Development

Table 75. Bio-Techne Corporation Company Detail

Table 76. Bio-Techne Corporation Business Overview

Table 77. Bio-Techne Corporation Therapeutic Recombinant Protein Product

Table 78. Bio-Techne Corporation Revenue in Therapeutic Recombinant Protein Business (2019-2024) & (US$ Million)

Table 79. Bio-Techne Corporation Recent Development

Table 80. Merck Company Detail

Table 81. Merck Business Overview

Table 82. Merck Therapeutic Recombinant Protein Product

Table 83. Merck Revenue in Therapeutic Recombinant Protein Business (2019-2024) & (US$ Million)

Table 84. Merck Recent Development

Table 85. ACROBiosystems Company Detail

Table 86. ACROBiosystems Business Overview

Table 87. ACROBiosystems Therapeutic Recombinant Protein Product

Table 88. ACROBiosystems Revenue in Therapeutic Recombinant Protein Business (2019-2024) & (US$ Million)

Table 89. ACROBiosystems Recent Development

Table 90. Abnova Company Detail

Table 91. Abnova Business Overview

Table 92. Abnova Therapeutic Recombinant Protein Product

Table 93. Abnova Revenue in Therapeutic Recombinant Protein Business (2019-2024) & (US$ Million)

Table 94. Abnova Recent Development

Table 95. Eurogentec (Kaneka Corporation) Company Detail

Table 96. Eurogentec (Kaneka Corporation) Business Overview

Table 97. Eurogentec (Kaneka Corporation) Therapeutic Recombinant Protein Product

Table 98. Eurogentec (Kaneka Corporation) Revenue in Therapeutic Recombinant Protein Business (2019-2024) & (US$ Million)

Table 99. Eurogentec (Kaneka Corporation) Recent Development

Table 100. Cytiva (Danaher ) Company Detail

Table 101. Cytiva (Danaher ) Business Overview

Table 102. Cytiva (Danaher ) Therapeutic Recombinant Protein Product

Table 103. Cytiva (Danaher ) Revenue in Therapeutic Recombinant Protein Business (2019-2024) & (US$ Million)

Table 104. Cytiva (Danaher ) Recent Development

Table 105. Reprocell Company Detail

Table 106. Reprocell Business Overview

Table 107. Reprocell Therapeutic Recombinant Protein Product

Table 108. Reprocell Revenue in Therapeutic Recombinant Protein Business (2019-2024) & (US$ Million)

Table 109. Reprocell Recent Development

Table 110. GenScript Company Detail

Table 111. GenScript Business Overview

Table 112. GenScript Therapeutic Recombinant Protein Product

Table 113. GenScript Revenue in Therapeutic Recombinant Protein Business (2019-2024) & (US$ Million)

Table 114. GenScript Recent Development

Table 115. BPS Bioscience Company Detail

Table 116. BPS Bioscience Business Overview

Table 117. BPS Bioscience Therapeutic Recombinant Protein Product

Table 118. BPS Bioscience Revenue in Therapeutic Recombinant Protein Business (2019-2024) & (US$ Million)

Table 119. BPS Bioscience Recent Development

Table 120. Sino Biological Company Detail

Table 121. Sino Biological Business Overview

Table 122. Sino Biological Therapeutic Recombinant Protein Product

Table 123. Sino Biological Revenue in Therapeutic Recombinant Protein Business (2019-2024) & (US$ Million)

Table 124. Sino Biological Recent Development

Table 125. Research Programs/Design for This Report

Table 126. Key Data Information from Secondary Sources

Table 127. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Therapeutic Recombinant Protein Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Therapeutic Recombinant Protein Market Share by Type: 2023 VS 2030

Figure 3. Hormones Features

Figure 4. Blood Clotting Factors Features

Figure 5. Cytokines Features

Figure 6. Enzymes Features

Figure 7. Fusion Proteins Features

Figure 8. Others Features

Figure 9. Global Therapeutic Recombinant Protein Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 10. Global Therapeutic Recombinant Protein Market Share by Application: 2023 VS 2030

Figure 11. Pharmaceutical Company Case Studies

Figure 12. Research Institute Case Studies

Figure 13. Others Case Studies

Figure 14. Therapeutic Recombinant Protein Report Years Considered

Figure 15. Global Therapeutic Recombinant Protein Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 16. Global Therapeutic Recombinant Protein Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 17. Global Therapeutic Recombinant Protein Market Share by Region: 2023 VS 2030

Figure 18. Global Therapeutic Recombinant Protein Market Share by Players in 2023

Figure 19. Global Top Therapeutic Recombinant Protein Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Therapeutic Recombinant Protein as of 2023)

Figure 20. The Top 10 and 5 Players Market Share by Therapeutic Recombinant Protein Revenue in 2023

Figure 21. North America Therapeutic Recombinant Protein Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. North America Therapeutic Recombinant Protein Market Share by Country (2019-2030)

Figure 23. United States Therapeutic Recombinant Protein Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Canada Therapeutic Recombinant Protein Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Therapeutic Recombinant Protein Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Europe Therapeutic Recombinant Protein Market Share by Country (2019-2030)

Figure 27. Germany Therapeutic Recombinant Protein Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. France Therapeutic Recombinant Protein Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. U.K. Therapeutic Recombinant Protein Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Italy Therapeutic Recombinant Protein Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Russia Therapeutic Recombinant Protein Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Nordic Countries Therapeutic Recombinant Protein Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Asia-Pacific Therapeutic Recombinant Protein Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Asia-Pacific Therapeutic Recombinant Protein Market Share by Region (2019-2030)

Figure 35. China Therapeutic Recombinant Protein Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Japan Therapeutic Recombinant Protein Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. South Korea Therapeutic Recombinant Protein Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Southeast Asia Therapeutic Recombinant Protein Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. India Therapeutic Recombinant Protein Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Australia Therapeutic Recombinant Protein Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Latin America Therapeutic Recombinant Protein Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Latin America Therapeutic Recombinant Protein Market Share by Country (2019-2030)

Figure 43. Mexico Therapeutic Recombinant Protein Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Brazil Therapeutic Recombinant Protein Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Middle East & Africa Therapeutic Recombinant Protein Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Middle East & Africa Therapeutic Recombinant Protein Market Share by Country (2019-2030)

Figure 47. Turkey Therapeutic Recombinant Protein Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Saudi Arabia Therapeutic Recombinant Protein Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. Abcam Revenue Growth Rate in Therapeutic Recombinant Protein Business (2019-2024)

Figure 50. HALIX Revenue Growth Rate in Therapeutic Recombinant Protein Business (2019-2024)

Figure 51. Avantor Revenue Growth Rate in Therapeutic Recombinant Protein Business (2019-2024)

Figure 52. Miltenyi Biotec Revenue Growth Rate in Therapeutic Recombinant Protein Business (2019-2024)

Figure 53. Thermo Fisher Scientific Revenue Growth Rate in Therapeutic Recombinant Protein Business (2019-2024)

Figure 54. Bio-Techne Corporation Revenue Growth Rate in Therapeutic Recombinant Protein Business (2019-2024)

Figure 55. Merck Revenue Growth Rate in Therapeutic Recombinant Protein Business (2019-2024)

Figure 56. ACROBiosystems Revenue Growth Rate in Therapeutic Recombinant Protein Business (2019-2024)

Figure 57. Abnova Revenue Growth Rate in Therapeutic Recombinant Protein Business (2019-2024)

Figure 58. Eurogentec (Kaneka Corporation) Revenue Growth Rate in Therapeutic Recombinant Protein Business (2019-2024)

Figure 59. Cytiva (Danaher ) Revenue Growth Rate in Therapeutic Recombinant Protein Business (2019-2024)

Figure 60. Reprocell Revenue Growth Rate in Therapeutic Recombinant Protein Business (2019-2024)

Figure 61. GenScript Revenue Growth Rate in Therapeutic Recombinant Protein Business (2019-2024)

Figure 62. BPS Bioscience Revenue Growth Rate in Therapeutic Recombinant Protein Business (2019-2024)

Figure 63. Sino Biological Revenue Growth Rate in Therapeutic Recombinant Protein Business (2019-2024)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-36U2606

Tue Oct 08 00:00:00 UTC 2024

Add to Cart

Sugar Excipients - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-34N7518

Tue Oct 08 00:00:00 UTC 2024

Add to Cart

Pharmaceutical Filtration Equipment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-36P1598

Tue Oct 08 00:00:00 UTC 2024

Add to Cart

Urinary Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-13F1831

Tue Oct 08 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Therapeutic Recombinant Protein Market Research Report 2024

Published Date: August 2024

Report Code: QYRE-Auto-6V14137

Global Therapeutic Recombinant Protein Market Research Report 2024

FEATURED COMPANIES

Therapeutic Recombinant Protein Market Size

Therapeutic Recombinant Protein Market

Report Scope

Scope of Therapeutic Recombinant Protein Market Report

Chapter Outline

FAQ for this report

Who are the main players in the Therapeutic Recombinant Protein Market report?

What are the Application segmentation covered in the Therapeutic Recombinant Protein Market report?

What are the Type segmentation covered in the Therapeutic Recombinant Protein Market report?

FEATURED COMPANIES

RELATED REPORTS